Follow The Filings

RVTY Revvity

Revvity earnings company data as of 5:01 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 3 Nov EPS 1.28 — —
Rev — — —

Insider trades

Open-market buys and sales by RVTY's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RVTY insider trades
  • None no insider bought on the open market
  • $58K sold by 1 insider outside a trading plan
  • $5.9M sold by 6 insiders under 10b5-1 plans
  1. Anita Gonzales VP and CAO
    Planned sale
    $13K 84 shares at $155.48 1.2% of stake
    Traded Oct 1 Filed Oct 2
  2. Maxwell Krakowiak Please See Remarks
    Planned sale
    $236K 1,631 shares at $144.53 9.9% of stake
    Traded Sep 21 Filed Sep 23
  3. Tajinder S Vohra Please See Remarks
    Planned sale
    $1M 7,330 shares at $140.88 53% of stake
    Traded Sep 16 Filed Sep 18
  4. Anita Gonzales Vice President and CAO
    Planned sale
    $9,306 85 shares at $109.48 1.2% of stake
    Traded Jul 20 Filed Jul 22
  5. Anita Gonzales Vice President and CAO
    Planned sale
    $7,424 80 shares at $92.80 1.1% of stake
    Traded Apr 20 Filed Apr 22
  6. Miriame Victor Please See Remarks
    Planned sale
    $181K 1,862 shares at $97.13 9.3% of stake
    Traded Feb 24 Filed Feb 26
  7. Michelle McMurry-Heath Director
    Sale
    $58K 600 shares at $97.26 12% of stake
    Traded Feb 23 Filed Feb 25
  8. Prahlad R. Singh Please See Remarks
    Planned sale
    $2.6M 25,525 shares at $100.21 18% of stake
    Traded Feb 5 Filed Feb 6
  9. Joel S Goldberg Please See Remarks
    Planned sale
    $1.3M 12,717 shares at $100.21 23% of stake
    Traded Feb 5 Filed Feb 6
  10. Tajinder S Vohra Please See Remarks
    Planned sale
    $602K 5,756 shares at $104.50 36% of stake
    Traded Feb 2 Filed Feb 4

Also filed in the last 12 months, not counted as buying or selling: 25 stock grants, 16 share withholdings for taxes, 9 gifts, and 4 option exercises.

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
8-K 2.02,8.01,9.01
SCHEDULE 13G/A —
10-Q
8-K 2.02,8.01,9.01
8-K 5.03,5.07,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —
DEF 14A
DEFA14A
10-K

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.